diff options
Diffstat (limited to 'markley/20_biblio')
| -rw-r--r-- | markley/20_biblio | 140 |
1 files changed, 140 insertions, 0 deletions
diff --git a/markley/20_biblio b/markley/20_biblio new file mode 100644 index 0000000..84da197 --- /dev/null +++ b/markley/20_biblio @@ -0,0 +1,140 @@ +https://en.wikipedia.org/wiki/Insulin_(medication) +https://en.wikipedia.org/wiki/Insulin_glargine + +https://www.sciencehistory.org/historical-profile/frederick-banting-charles-best-james-collip-and-john-macleod + A history of insulin, and the ?two? researchers who discovered that + pig insulin was able to be substituted in dogs and in people + +http://www.madehow.com/Volume-7/Insulin.html +- (bad source) how insulin is made + +https://gh.bmj.com/content/3/5/e000850 +https://pubmed.ncbi.nlm.nih.gov/30271626/ + - Read the article through the GT paywall (PubMed) + - About how much insulin costs to manufacture + +phttps://www.citizen.org/article/outrage-of-the-month-pharmas-price-gouging-on-insulin-is-literally-killing-patients/ + - Has some valuable links, about how much Insulin is costing + +https://www.youtube.com/watch?v=SYmvBoXi0Q8 + - Channel 4 AOC talking about Campaign Finance + +http://web.a.ebscohost.com.prx.library.gatech.edu/ehost/pdfviewer/pdfviewer?vid=1&sid=88e625e8-0732-4c85-aa12-a8b8cd5ded42%40sessionmgr4008 + - Behind the paywall, I think + - Insulin. + - Some upcoming results about the a + +https://www.opensecrets.org/political-action-committees-pacs/C00144345/summary/2020 + - More money in finance stuff + - Sanofi PAC gave nearly a million, with $5K donations from employes + +https://www.opensecrets.org/orgs/aetna-inc/totals?id=D000000296#totals-affiliates + - Aetna money in finance + +https://www.usatoday.com/story/news/politics/2019/08/26/pharma-industry-ups-donations-senate-republicans-mcconnell/2116231001/ +https://www.statnews.com/feature/prescription-politics/prescription-politics/ + - General pharma industry payoffs from USA Today (meh) + +https://search.proquest.com/docview/1829913470?rfr_id=info%3Axri%2Fsid%3Aprimo + - Behind the paywall + - FDA about DMCA exemption for medical devices + +https://doggett.house.gov/media-center/press-releases/doggett-brown-announce-bicameral-medicare-drug-price-negotiation-bill + - Lloyd Doggett's website + - From the Public Citizen website about Medicare Negotiations + +https://go.gale.com/ps/retrieve.do?tabID=T003&resultListType=RESULT_LIST&searchResultsType=SingleTab&hitCount=11184&searchType=BasicSearchForm¤tPosition=12&docId=GALE%7CA640027797&docType=Article&sort=Relevance&contentSegment=ZGPP-MOD1&prodId=ITOF&pageNum=1&contentSet=GALE%7CA640027797&searchId=R2&userGroupName=gainstoftech&inPS=true + - I don't understand it, but Patent board rules in Sanofi's favor + over a patent on PCSK9 antibodies (?) + +https://gatech-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_miscellaneous_1698956637&context=PC&vid=01GALI_GIT&lang=en_US&search_scope=primo_central&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,insulin&offset=0 + - Generic insulin glargine?? + - About its efficacy in a double-blind trial + +https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2717499 +- Cost-related insulin underuse + +https://www.openmarketsinstitute.org/learn/drug-prices-monopoly +- "Between 1995 and 2015, 60 pharmaceutical companies merged into just + 10." +- Def not behind paywall but wow +- Lotsa good links +- the nber.org link is from this, I think +- Haven't finished reading + +https://pubmed.ncbi.nlm.nih.gov/24866023/ +- "Insulin glargine was the first once-daily, long-acting insulin analog + to be introduced into clinical practice more than 10 years ago and is + specifically designed to provide basal insulin requirements." +- Nice pubmed article (paywall) +"pancreatectomized dogs" + +https://patents.google.com/patent/US8048854B2/en +- The patent itself +- Gives a date of 2027-07-05 for expiry + +https://www.npr.org/templates/story/story.php?storyId=1869210 +- 4:33 segment +- "Drug Companies Cope with Declines, May Merge" +- About the Sanofi-Aventus merger in 2004. The problem with the industry + is "a lack of new drugs" + +https://healthcostinstitute.org/diabetes-and-insulin/spending-on-individuals-with-type-1-diabetes-and-the-role-of-rapidly-increasing-insulin-prices +- Some pricing data on per-unit, increases in 2012--2016, other stuff + +https://www.sanofi.com/en/about-us/through-time/ +- Sanofi's company history: Hoechst, Synthelabo, and Phone-Poulenc Rorer +- https://en.wikipedia.org/wiki/Hoechst_AG + - It was a holocaust bad +- Merger of like four companies (wtf) = $126B mkt cap (SNY) + +https://www-proquest-com.prx.library.gatech.edu/docview/1664805626?accountid=11107 +- Why is there no generic insulin? +- Kinda limited explanation +- Behind the paywall + +https://www.proquest.com/docview/223927797/5F156A7B9D3F4195PQ/1?accountid=11107 +- Corporate Payoffs and Pravix from Sanofi +- 2006 +- Behind the paywall + +https://www.ftc.gov/news-events/media-resources/mergers-competition/pay-delay +- FTC recent paydelay stuff + +https://www.drugs.com/nda/mk_1293_160805.html +- Semi-reliable, probably (not a good enough source, maybe) +- Press release +- Lusduna Nexvue, a tentatively approved follow-on for glargine +https://www.fiercepharma.com/marketing/despite-scoring-fda-nod-merck-s-follow-med-lusduna-must-wait-to-challenge-lantus +- Doesn't exactly fit the narrative, but these are other big companies + - Plus the Hatch whatever act + - Nevermind, it does. So these massive companies just got into the + mkt to sell at the $300 prices. WTF +- Sanofi has two competitor insulin glargines + +https://projects.propublica.org/represent/lobbying/search?commit=Search&fields%5B%5D=_all&page=2&search=sanofi&utf8=%E2%9C%93 +- The current lobbying projects that Sanofi is doing. I didn't get much + +https://www.opensecrets.org/Lobby/clientsum.php?id=D000000215&year=2020 +- Another lobbying site +- Sanofi put out $4M in lobbying! + +https://go.gale.com/ps/i.do?p=GPS&u=gainstoftech&id=GALE|A202627653&v=2.1&it=r +- 2009: "Sanofi-Aventis in acquisition mode" +- Uhh I don't think this will be useful, but it's here. + - What I really want to know is how many companies has Sanofi/its + predecessors acquired. + +https://pharmaphorum.com/articles/a_history_of-_sanofi/ +- Might be a wiki citation, so good +- Includes some merger info, might be incomplete on the Aventis side but + prob pretty comprehensive + +https://www.nber.org/system/files/working_papers/w7280/w7280.pdf +- I didn't have time to read it +- 60 pages on antitrust laws (and court?) + +https://go.gale.com/ps/retrieve.do?tabID=Journals&resultListType=RESULT_LIST&searchResultsType=MultiTab&hitCount=6&searchType=BasicSearchForm¤tPosition=2&docId=GALE%7CA101569966&docType=Article&sort=Relevance&contentSegment=ZICC-MOD1&prodId=CSIC&pageNum=1&contentSet=GALE%7CA101569966&searchId=R2&userGroupName=gainstoftech&inPS=true +- "Physicians and the pharmaceutical industry: a dysfunctional + relationship" +- Skimmed it. Seems useful? |